Shenzhen Kangtai Biological Products Co., Ltd. (SHE:300601)

SHE:300601 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	216.2	432.84	1,196	1,018	3,550	882.69
Short-Term Investments	2,191	2,174	463.34	531.58	725.57	-
Trading Asset Securities	30.06	-	100.02	440.83	-	2,155
Cash & Short-Term Investments	2,438	2,607	1,759	1,990	4,275	3,038
Cash Growth	221.80%	48.21%	-11.61%	-53.45%	40.73%	501.29%
Accounts Receivable	2,913	2,787	2,788	2,293	1,858	1,613
Other Receivables	9.67	10.54	8.9	11.38	14.25	59.09
Receivables	2,923	2,798	2,797	2,305	1,872	1,672
Inventory	679.58	782.77	772.85	727.8	1,058	436.55
Other Current Assets	50.69	55.09	67.51	152.34	135.14	197.71
Total Current Assets	6,091	6,242	5,396	5,175	7,341	5,345
Property, Plant & Equipment	5,093	5,225	5,716	5,176	4,116	2,279
Long-Term Investments	712.14	-	311.68	302.38	105.64	101.71
Other Intangible Assets	415.05	436.66	433.45	357.98	346.04	294.36
Long-Term Deferred Tax Assets	732.93	697.63	630.32	708.32	558.6	702.05
Long-Term Deferred Charges	282.46	268.26	172.47	195.95	489.6	195.57
Other Long-Term Assets	802.39	1,693	2,425	1,871	1,192	667.18
Total Assets	14,129	14,564	15,085	13,786	14,149	9,585
Accounts Payable	704.59	847.83	882.48	434.13	708.2	167.36
Accrued Expenses	1,350	1,358	1,595	1,330	807.26	798.67
Short-Term Debt	39.9	34.1	60.04	170.07	777.53	11.32
Current Portion of Long-Term Debt	-	202.95	32.32	103.61	22.6	12.07
Current Income Taxes Payable	-	6.32	-	-	65.64	-
Current Unearned Revenue	21.42	19.28	28.76	31.23	94.51	14.95
Other Current Liabilities	171.53	178.17	152.69	270.96	142.39	751.57
Total Current Liabilities	2,287	2,647	2,751	2,340	2,618	1,756
Long-Term Debt	1,829	1,786	2,372	2,016	1,938	67.8
Long-Term Unearned Revenue	240.09	247.82	328.7	383.1	349.54	278.5
Long-Term Deferred Tax Liabilities	31.2	34.52	26.89	26.08	41.47	18.83
Other Long-Term Liabilities	143.12	186.72	64.51	36.33	35.13	-
Total Liabilities	4,530	4,903	5,544	4,801	4,982	2,121
Common Stock	1,117	1,117	1,117	1,120	687.09	684.93
Additional Paid-In Capital	5,512	5,511	5,369	5,490	5,357	5,265
Retained Earnings	2,460	2,523	2,544	1,884	2,612	1,555
Treasury Stock	-	-	-	-20	-0.55	-41.55
Comprehensive Income & Other	510.86	510.95	511.1	511.14	511.3	-
Total Common Equity	9,599	9,661	9,542	8,985	9,167	7,463
Minority Interest	-0.03	-0.1	-	-	-	-
Shareholders' Equity	9,599	9,661	9,542	8,985	9,167	7,463
Total Liabilities & Equity	14,129	14,564	15,085	13,786	14,149	9,585
Total Debt	1,868	2,024	2,465	2,289	2,738	91.19
Net Cash (Debt)	569.18	583.32	-705.64	-299.34	1,537	2,947
Net Cash Growth	-	-	-	-	-47.84%	1082.44%
Net Cash Per Share	0.48	0.52	-0.63	-0.27	1.38	2.74
Filing Date Shares Outstanding	1,117	1,117	1,117	1,120	1,120	1,096
Total Common Shares Outstanding	1,117	1,117	1,117	1,120	1,099	1,096
Working Capital	3,804	3,595	2,645	2,835	4,723	3,589
Book Value Per Share	8.59	8.65	8.54	8.02	8.34	6.81
Tangible Book Value	9,184	9,224	9,108	8,627	8,821	7,169
Tangible Book Value Per Share	8.22	8.26	8.15	7.70	8.02	6.54
Buildings	2,749	2,780	2,718	1,037	939.37	859.63
Machinery	2,907	2,840	1,853	1,671	1,682	731.24
Construction In Progress	959.93	990.28	2,281	3,463	2,320	1,136

Source: S&P Global Market Intelligence. Standard template. Financial Sources.